AdvertisementCDC, FDA To Review J&J Shot After 6 Blood Clot Cases Reported Out Of Nearly 7M DosesUpdated April 13, 2021Scott NeumanfacebookEmailThe U.S. Food and Drug Administration and the Centers for Disease Control and Prevention have recommended a pause in the use of the Johnson & Johnson COVID-19 vaccine, shown here in a hospital in Denver. (AP)This article was originally published on April 13, 2021.